Anxiety, depressive, and panic disorders are all common psychiatric comorbidities found in patients with migraine and headache disorders.
Your search for major depressive disorder returned 73 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
A placebo-controlled study of smokers with MDD evaluated varenicline with vs without behavioral interventions for smoking cessation.
The FDA has approved Rexulti (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer disease.
A study was conducted to determine the effects of switching or augmenting antidepressant therapy in adults with treatment-resistant depression.
Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.
In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.
Treatment-resistant depression episodes tied to more psychiatric comorbid conditions, health care utilization, self-harm, and all-cause mortality
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Being married, having a confidant associated with better mental health with COPD
Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity
What is the link between multiple sclerosis and depression, and how can you help patients with their mental health?
Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.
Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for children aged 8 to 18 years
Looking at stress and university students during the COVID-19 pandemic.
Individuals with severe mental illness or T2DM have increased levels of peripheral immune-inflammatory biomarkers, which may contribute to neurocognitive and social deficits.
To learn more about the impact of depression therapy on anxiety symptoms, researchers conducted a randomized controlled clinical trial with teenagers to compare the results of personalized depression therapy to a program that does not match their risk factors.
In addition to the physical risks, experts anticipate a myriad of mental health ramifications stemming from the loss of abortion access and the associated economic and occupational repercussions.
Researchers explored the neurobiology related to reward-based reinforcement learning and psychomotor retardation in patients in remission from MDD.
Given the ethnic and racial disparities in the US, researchers examined whether SDoH contributed to racial and ethnic disparities in cognition, health, and depression.
In a systematic literature review, researchers determined the global prevalence of head trauma among refugees and asylum seekers and described its common clinical characteristics in this population.
Investigators searched publication databases for studies of depression among perinatal women on the basis of country income status.
Investigators designed this study to evaluate the feasibility and potential utility of a peer-led CBT-based workshop for PPD.
Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.
Researcher sought to assess how timing, frequency, and maintenance of physical activity in adulthood, over the span of 30 years, is associated with cognitive function later in life.
Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.
According to a new poll, more than 90% of adults who reported they get good sleep were also free of depressive symptoms.
Being physically active at any point during adulthood is associated with a higher later-life cognitive state.
Inpatients with schizophrenia spectrum disorders were randomly assigned to receive treatment as usual with or without a yoga-based group intervention for 4 weeks.
The REAL-ESK study was an observational, retrospective, multicenter study conducted in Italy.
Researchers sought to characterize real-world efficacy of repeated ketamine infusions for treatment-resistant bipolar depression assessing symptoms of depression, anxiety, suicidality, and functioning.
Latest News Your top articles for SaturdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses